PlainRecalls
FDA Drug Moderate Class II Terminated

Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60.

Reported: October 16, 2019 Initiated: October 7, 2019 #D-0139-2020

Product Description

Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60.

Reason for Recall

Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.

Details

Units Affected
19,165 vials
Distribution
Nationwide in the USA
Location
Bangalore, N/A

Frequently Asked Questions

What product was recalled?
Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60.. Recalled by Mylan Laboratories Limited (Sterile Products Division). Units affected: 19,165 vials.
Why was this product recalled?
Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 16, 2019. Severity: Moderate. Recall number: D-0139-2020.